HPV Testing and Pap Test Market Estimated to Reach $9.2 Billion by 2027
The HPV testing and Pap test market is witnessing substantial growth and is projected to reach USD 9.2 billion by 2027, with a CAGR of 13.2%. This growth is primarily attributed to the development of new cervical cancer diagnostic products and strong government support. Emerging economies like India and Japan are providing lucrative opportunities for companies operating in this market. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=214207371 Market Segmentation By Test Type: The HPV testing and Pap test market is segmented into HPV testing and Pap Test. The HPV testing segment holds the largest share in the market due to the increasing demand for cervical cancer diagnostic products. By Application: The market is further segmented into cervical cancer screening and vaginal cancer screening. The cervical cancer screening segment dominates the market, driven by growing public awareness about cervical cancer. By End User: Based on end-user, th...